PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Pharmacy, HPNP 3317, University of Florida , Gainesville, FL, USA.\', \'Department of Pharmaceutical Business and Administration Sciences, MCPHS University , Boston, MA, USA.\', \'Théorie Économique, Modélisation et Applications (ThEMA), Université de Cergy-Pontoise, France and Ecole Nationale Supérieure de Statistiques et d\'Economie Appliquée (ENSEA).\', \'Northwest Territories Government , Yellowknife, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/14737167.2021.1851600
?:doi
?:hasPublicationType
?:journal
  • Expert review of pharmacoeconomics & outcomes research
is ?:pmid of
?:pmid
?:pmid
  • 33186061
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33186061>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33186061>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all